SAM
ASTX

Sandell Asset Management’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

Sandell Asset Management’s Portfolio ASTX Stock Details ASTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-2,107,445
Closed -$17.9M – 43
2013
Q3 		$17.9M Buy
+2,107,445
New +$13.3M 3.1% 15

Sandell Asset Management's ASTX Position: Q4 2013 in Review

Sandell Asset Management sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 2,107,445 shares — an estimated $17.9M sold.

Sandell Asset Management first reported a position in ASTX in Q3 2013 and held it in 1 quarter. The position peaked at $17.9M in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • Sandell Asset Management reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • Sandell Asset Management sold 2,107,445 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $17.9M.
  • Sandell Asset Management first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q3 2013 and held it in 1 quarter.
  • Sandell Asset Management's ASTEX PHARMACEUTICALS, INC COM position peaked at $17.9M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on Sandell Asset Management's 13F filing for Q4 2013, filed 12 Feb 2014.